|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM350837007 |
| 003 |
DE-627 |
| 005 |
20231226045907.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2023 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2022.109216
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1169.xml
|
| 035 |
|
|
|a (DE-627)NLM350837007
|
| 035 |
|
|
|a (NLM)36572212
|
| 035 |
|
|
|a (PII)S1521-6616(22)00297-2
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Gupta, Saloni
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Inflammation driven metabolic regulation and adaptation in macrophages
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 17.01.2023
|
| 500 |
|
|
|a Date Revised 12.02.2023
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2022 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a Macrophages are a diverse population of phagocytic immune cells involved in the host defense mechanisms and regulation of homeostasis. Usually, macrophages maintain healthy functioning at the cellular level, but external perturbation in their balanced functions can lead to acute and chronic disease conditions. By sensing the cues from the tissue microenvironment, these phagocytes adopt a plethora of phenotypes, such as inflammatory or M1 to anti-inflammatory (immunosuppressive) or M2 subtypes, to fulfill their spectral range of functions. The existing evidence in the literature supports that in macrophages, regulation of metabolic switches and metabolic adaptations are associated with their functional behaviors under various physiological and pathological conditions. Since these macrophages play a crucial role in many disorders, therefore it is necessary to understand their heterogeneity and metabolic reprogramming. Consequently, these macrophages have also emerged as a promising target for diseases in which their role is crucial in driving the disease pathology and outcome (e.g., Cancers). In this review, we discuss the recent findings that link many metabolites with macrophage functions and highlight how this metabolic reprogramming can improve our understanding of cellular malfunction in the macrophages during inflammatory disorders. A systematic analysis of the interconnecting crosstalk between metabolic pathways with macrophages should inform the selection of immunomodulatory therapies for inflammatory diseases
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 650 |
|
4 |
|a Inflammatory diseases
|
| 650 |
|
4 |
|a Krebs cycle
|
| 650 |
|
4 |
|a Macrophages
|
| 650 |
|
4 |
|a Metabolic reprogramming
|
| 650 |
|
4 |
|a Therapeutics
|
| 650 |
|
7 |
|a Anti-Inflammatory Agents
|2 NLM
|
| 700 |
1 |
|
|a Sarangi, Pranita P
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 246(2023) vom: 01. Jan., Seite 109216
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:246
|g year:2023
|g day:01
|g month:01
|g pages:109216
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2022.109216
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 246
|j 2023
|b 01
|c 01
|h 109216
|